Article Details

Bayer kidney disease drug gets FDA nod, pitting it against AstraZeneca, J&J meds

Retrieved on: 2021-07-11 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Bayer kidney disease drug gets FDA nod, pitting it against AstraZeneca, J&J meds. View article details on hiswai:

Excerpt

The drug is the first in its class, giving the pharma giant an alternative way to compete against medicines already marketed by AstraZeneca and Bayer.

Article found on: medcitynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up